It is critical to recognize early abnormalities of glucose and insulin metabolism in order to prevent progression of type 2 diabetes and cardiovascular comorbidities associated with hyperinsulinemia and glucose intolerance. The gene discussed is INS; the disease is hyperinsulinism.